HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
INDV
Indivior Plc
Healthcare Drug Manufacturers - Specialty & Generic ADR · United Kingdom · Reports in usd
Market Cap: $4.21B
Market Cap
$4.21B
Enterprise Val
$4.50B
P/E Ratio
11.87
P/B Ratio
-20.26
Trailing PEG (1Y)
0.02
As Of
Aug 31, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value-$208.0M
Gross Margin85.42%
Profit Margin85.42%
Return on Equity-216.13%
Return on Assets28.14%
Current Ratio0.84
Debt/Equity-2.45
LT Debt/Equity-2.40
Revenue Per Share2.81

Income Statement

Jun 30, 2026
Revenue$343.0M
Cost of Revenue$50.0M
Gross Profit$293.0M
R&D$12.0M
SG&A$122.0M
Operating Expenses$134.0M
Operating Income$159.0M
Interest Expense$2.0M
Tax Expense$38.0M
Net Income$122.0M
EPS (Basic)$1.02
EPS (Diluted)$0.98
EBIT$162.0M
EBITDA$165.0M
Consolidated Income$122.0M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$222.0M
Accounts Receivable$271.0M
Inventory$150.0M
Current Assets$725.0M
LT Investments$27.0M
Property, Plant & Equipment$183.0M
Intangibles$2.0M
Non-Current Assets$508.0M
Total Assets$1.23B
Accounts Payable$206.0M
Current Debt$9.0M
Current Liabilities$868.0M
LT Debt$500.0M
Non-Current Liabilities$573.0M
Total Liabilities$1.44B
Total Debt$509.0M
Retained Earnings-$334.0M
Shareholder Equity-$208.0M
Shares Outstanding121,922,058

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$229.0M
Investing Cash Flow-$8.0M
Financing Cash Flow-$173.0M
CapEx-$7.0M
Free Cash Flow$222.0M
Depreciation & Amort.$3.0M
Stock-Based Comp$11.0M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$176.0M
Dividends Paid$0.00
Net Change in Cash$48.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h